Ultrasounds Evaluation of Asymptomatic Perimandibular Muscles Treated With Dry Needling
12 ottobre 2020 aggiornato da: Alice Botticchio, Poliambulatorio Physio Power
Morphological Changes in Asymptomatic Perimandibular Muscles After Dry Needling Assessed With Rehabilitative Ultrasound Imaging
The articular disc of temporomandibular joint and three muscles of the cervico-facial region (temporal, masseter, sternocleidomastoid) are evaluated by means of sonographic images to observe and measure their dimensions' changes after a dry needling intervention.
The participants are asymptomatic subjects and will be randomly divided in 2 groups: half of them are treated on the right side of the face, while the other half on the left side.
Our hypothesis is that ultrasonography can reveal changes in the structures measured on the treated side.
Panoramica dello studio
Stato
Completato
Intervento / Trattamento
Descrizione dettagliata
The trial is designed as a before-and-after study conducted on asymptomatic subjects. The aim is to assess temporomandibular joint and three perimandibular muscles (temporal, masseter, sternocleidomastoid) by means of rehabilitative ultrasound imaging, carried out by a novice clinician. These evaluations are performed before and after a dry needling treatment directed to the tree studied muscles of one side of the face. The side to be treated is randomly assigned by using a computer-generated randomization process, the other side is used as control.
One month after the treatment sonographic images are taken by the novice clinician and by an expert one. The aim is to assess the reliability of ultrasonography comparing the results of their assessments.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
17
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Madrid
-
Pozuelo De Alarcón, Madrid, Spagna, 28223
- Universidad Francisco de Vitoria
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
18 anni e precedenti (Adulto, Adulto più anziano)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- Age major then 18 years
- Must be asymptomatic in the face/head region at the time of the visit and in the previous 6 months.
Exclusion Criteria:
- Pregnancy
- medical history of systemic disease
- current pharmacological therapy
- history of recurrent headache and/or neck pain
- presence of orofacial pain or temporomandibular symptoms assessed with the DC/TMD (Diagnostic Criteria for TemporoMandibular Disorders)
- current use of a bite during sleep
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: dry needling group
Dry needling treatment on right or left side of the face (depending on randomization)
|
The use of filiform needles to stimulate muscles and connective tissues.
The needle is inserted in a direction perpendicular to the skin, a local twitch response is looked for and, once found, the needle is kept in the muscle without moving for 10 seconds.
No substances are injected.
|
|
Nessun intervento: control group
No treatment on left or right side of the face (depending on randomization)
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
mean of temporomandibular joint disc thickness
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the distance between the opposing surfaces of the disc (cm)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
|
mean of temporal muscle thickness
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the distance between the opposing borders of the muscle, along the transverse axis of the muscle (cm)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
|
mean of masseter muscle thickness
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the distance between the superficial and the deep border of the muscle (cm)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
|
mean of masseter muscle width
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the distance between the opposing extremities of the muscle along the transverse axis of the muscle (cm)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
|
mean of masseter muscle cross-sectional area
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the area of the muscle in transversal plan measured after drawing the outline of the muscle in an image obtained with the panoramic view function (cm2)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
|
mean of sternocleidomastoid muscle thickness
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the distance between the superficial and the deep border of the muscle (cm)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
|
mean of sternocleidomastoid muscle width
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the distance between the opposing extremities of the muscle along the transverse axis of the muscle (cm)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
|
mean of sternocleidomastoid muscle cross-sectional area
Lasso di tempo: Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
the area of the muscle in transversal plan measured after drawing the outline of the muscle in an image obtained with the panoramic view function (cm2)
|
Baseline (before the treatment), immediately after the treatment, one month after the treatment
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
mean of maximum mouth opening
Lasso di tempo: Baseline (before the treatment), one month after the treatment
|
the distance between the superior border of inferior front teeth and the inferior border of superior front teeth (cm)
|
Baseline (before the treatment), one month after the treatment
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Alice Botticchio, PT, OMPT, Poliambulatorio PhysioPower, Brescia, Italy
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Pubblicazioni generali
- Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151.
- Dahlstrom L, Carlsson GE. Temporomandibular disorders and oral health-related quality of life. A systematic review. Acta Odontol Scand. 2010 Mar;68(2):80-5. doi: 10.3109/00016350903431118.
- Dunning J, Butts R, Mourad F, Young I, Flannagan S, Perreault T. Dry needling: a literature review with implications for clinical practice guidelines. Phys Ther Rev. 2014 Aug;19(4):252-265. doi: 10.1179/108331913X13844245102034.
- de-Pedro-Herraez M, Mesa-Jimenez J, Fernandez-de-Las-Penas C, de-la-Hoz-Aizpurua JL. Myogenic temporomandibular disorders: Clinical systemic comorbidities in a female population sample. Med Oral Patol Oral Cir Bucal. 2016 Nov 1;21(6):e784-792. doi: 10.4317/medoral.21249.
- Ries LG, Alves MC, Berzin F. Asymmetric activation of temporalis, masseter, and sternocleidomastoid muscles in temporomandibular disorder patients. Cranio. 2008 Jan;26(1):59-64. doi: 10.1179/crn.2008.008.
- Oliveira LK, Almeida Gde A, Lelis ER, Tavares M, Fernandes Neto AJ. Temporomandibular disorder and anxiety, quality of sleep, and quality of life in nursing professionals. Braz Oral Res. 2015;29:S1806-83242015000100265. doi: 10.1590/1807-3107BOR-2015.vol29.0070.
- Weiss RC, Oostrom-Ram T. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro. Vet Microbiol. 1989 Jul;20(3):255-65. doi: 10.1016/0378-1135(89)90049-7.
- Emshoff R, Bertram S, Strobl H. Ultrasonographic cross-sectional characteristics of muscles of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Jan;87(1):93-106. doi: 10.1016/s1079-2104(99)70302-1.
- Djordjevic O, Djordjevic A, Konstantinovic L. Interrater and intrarater reliability of transverse abdominal and lumbar multifidus muscle thickness in subjects with and without low back pain. J Orthop Sports Phys Ther. 2014 Dec;44(12):979-88. doi: 10.2519/jospt.2014.5141. Epub 2014 Nov 3.
- Strini PJ, Strini PJ, Barbosa Tde S, Gaviao MB. Assessment of thickness and function of masticatory and cervical muscles in adults with and without temporomandibular disorders. Arch Oral Biol. 2013 Sep;58(9):1100-8. doi: 10.1016/j.archoralbio.2013.04.006. Epub 2013 May 16.
- Pallegama RW, Ranasinghe AW, Weerasinghe VS, Sitheeque MA. Influence of masticatory muscle pain on electromyographic activities of cervical muscles in patients with myogenous temporomandibular disorders. J Oral Rehabil. 2004 May;31(5):423-9. doi: 10.1111/j.1365-2842.2004.01266.x.
- Fedorowicz Z, van Zuuren EJ, Schoones J. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev. 2013 Sep 9;2013(9):CD007510. doi: 10.1002/14651858.CD007510.pub3.
- Ariji Y, Sakuma S, Izumi M, Sasaki J, Kurita K, Ogi N, Nojiri M, Nakagawa M, Takenaka M, Katsuse S, Ariji E. Ultrasonographic features of the masseter muscle in female patients with temporomandibular disorder associated with myofascial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):337-41. doi: 10.1016/j.tripleo.2004.06.068.
- Gonzalez-Perez LM, Infante-Cossio P, Granados-Nunez M, Urresti-Lopez FJ, Lopez-Martos R, Ruiz-Canela-Mendez P. Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction. Med Oral Patol Oral Cir Bucal. 2015 May 1;20(3):e326-33. doi: 10.4317/medoral.20384.
- Diracoglu D, Vural M, Karan A, Aksoy C. Effectiveness of dry needling for the treatment of temporomandibular myofascial pain: a double-blind, randomized, placebo controlled study. J Back Musculoskelet Rehabil. 2012;25(4):285-90. doi: 10.3233/BMR-2012-0338.
- Turo D, Otto P, Hossain M, Gebreab T, Armstrong K, Rosenberger WF, Shao H, Shah JP, Gerber LH, Sikdar S. Novel Use of Ultrasound Elastography to Quantify Muscle Tissue Changes After Dry Needling of Myofascial Trigger Points in Patients With Chronic Myofascial Pain. J Ultrasound Med. 2015 Dec;34(12):2149-61. doi: 10.7863/ultra.14.08033. Epub 2015 Oct 21.
- Emshoff R, Bertram S, Rudisch A, Gassner R. The diagnostic value of ultrasonography to determine the temporomandibular joint disk position. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Dec;84(6):688-96. doi: 10.1016/s1079-2104(97)90374-7.
- Raadsheer MC, Van Eijden TM, Van Spronsen PH, Van Ginkel FC, Kiliaridis S, Prahl-Andersen B. A comparison of human masseter muscle thickness measured by ultrasonography and magnetic resonance imaging. Arch Oral Biol. 1994 Dec;39(12):1079-84. doi: 10.1016/0003-9969(94)90061-2.
- Cagnie B, Dewitte V, Barbe T, Timmermans F, Delrue N, Meeus M. Physiologic effects of dry needling. Curr Pain Headache Rep. 2013 Aug;17(8):348. doi: 10.1007/s11916-013-0348-5.
- Smith P, Mosscrop D, Davies S, Sloan P, Al-Ani Z. The efficacy of acupuncture in the treatment of temporomandibular joint myofascial pain: a randomised controlled trial. J Dent. 2007 Mar;35(3):259-67. doi: 10.1016/j.jdent.2006.09.004. Epub 2006 Nov 13.
- Hides J, Richardson C, Jull G, Davies S. Ultrasound imaging in rehabilitation. Aust J Physiother. 1995;41(3):187-93. doi: 10.1016/S0004-9514(14)60429-3.
- Hodges PW. Ultrasound imaging in rehabilitation: just a fad? J Orthop Sports Phys Ther. 2005 Jun;35(6):333-7. doi: 10.2519/jospt.2005.0106. No abstract available.
- Teyhen DS. Rehabilitative ultrasound imaging for assessment and treatment of musculoskeletal conditions. Man Ther. 2011 Feb;16(1):44-5. doi: 10.1016/j.math.2010.06.012. Epub 2010 Aug 1. No abstract available.
- Bubnov RV. The use of trigger point "dry" needling under ultrasound guidance for the treatment of myofascial pain (technological innovation and literature review). Lik Sprava. 2010 Jul-Sep;(5-6):56-64.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
6 gennaio 2020
Completamento primario (Effettivo)
20 febbraio 2020
Completamento dello studio (Effettivo)
20 febbraio 2020
Date di iscrizione allo studio
Primo inviato
1 ottobre 2020
Primo inviato che soddisfa i criteri di controllo qualità
6 ottobre 2020
Primo Inserito (Effettivo)
8 ottobre 2020
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
14 ottobre 2020
Ultimo aggiornamento inviato che soddisfa i criteri QC
12 ottobre 2020
Ultimo verificato
1 ottobre 2020
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- US-DN-01
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
No
Descrizione del piano IPD
We are not intentioned to share the participant data as our outcomes are subjectively evaluated by the use of ultrasonography.
We don't believe it will be helpful for other researches as the results will be interpreted by our assessors.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Stato asintomatico
-
University of AberdeenSouth Eastern Health and Social Care TrustCompletatoMadri che sono state segnalate per il supporto genitorialeRegno Unito
-
Abramson Cancer Center of the University of PennsylvaniaRitiratoDonne adulte con una nuova diagnosi di carcinoma mammario invasivo (non sono state sottoposte a trattamento)
-
Ziqiang LiAttivo, non reclutanteDati statistici completi e accurati di 60 pazienti | I genotipi CYP3A5*3 di 60 donatori e riceventi sono stati analizzati accuratamente | Le concentrazioni postoperatorie di tacrolimus sono state accuratamente registrate in 60 pazienti | Secondo i criteri di diagnosi e classificazione della... e altre condizioniCina
Prove cliniche su dry needling
-
University of Castilla-La ManchaCompletatoTrigger Point Dolore, MiofascialeSpagna
-
University of Castilla-La ManchaCompletatoTrigger Point Dolore, MiofascialeSpagna
-
University of Castilla-La ManchaUniversidad San Jorge; Hospital Nacional de Parapléjicos de ToledoCompletatoAnomalie del tono muscolareSpagna
-
Cardenal Herrera UniversityCompletato
-
Riphah International UniversityCompletatoGinocchio del corridorePakistan
-
University of FloridaReclutamento
-
Army-Baylor University Doctoral Program in Physical...Brooke Army Medical CenterCompletatoDolore cronico | Dolore alla spalla | Lesione muscoloscheletricaStati Uniti
-
Universidad Complutense de MadridCompletato
-
Emily Slaven, PT, PhDMount St Joseph UniversityCompletatoDebolezza muscolare | Punto di innescoStati Uniti
-
Emory UniversityCompletatoFascite plantare | Sindrome dolorosa femoro-rotulea | Tendinite d'AchilleStati Uniti